US Department of Defense supports an AlgiPharma initiated in vivo wound healing study on OligoG

AlgiPharma has together with Prof. Chandan Sen, at Ohio State University embarked on a study to investigate the effects of OligoG in a unique biofilm infected in vivo wound healing model. For further information, please contact: Philip D. Rye R&D Director; [email protected] August 2010

The release as fetched from its publisher. algipharma.com ↗